Medlive Technology Co (HKSE:02192) EPS (Diluted) : HK$0.36 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co EPS (Diluted)?

Medlive Technology Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.21. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.36.

Medlive Technology Co's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.22. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.37.

Medlive Technology Co's EPS without NRI for the six months ended in Dec. 2023 was HK$0.21. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.36.

During the past 12 months, Medlive Technology Co's average EPS without NRIGrowth Rate was 103.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 35.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 60.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Medlive Technology Co's highest 3-Year average EPS without NRI Growth Rate was 51.40% per year. The lowest was 35.40% per year. And the median was 48.10% per year.

Medlive Technology Co EPS (Diluted) Historical Data

The historical data trend for Medlive Technology Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co EPS (Diluted) Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

0.05

0.15

0.08

0.18

0.36

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial					0.04	0.04	0.14	0.15	0.21

Competitive Comparison of Medlive Technology Co's EPS (Diluted)

For the Medical Distribution subindustry, Medlive Technology Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's PE Ratio falls into.

Medlive Technology Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Medlive Technology Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(265.024	-	0)	/	734.583
	=	0.36

Medlive Technology Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(157.048	-	0)	/	732.102
	=	0.21

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.36

Medlive Technology Co (HKSE:02192) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medlive Technology Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines